Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 114

Similar articles for PubMed (Select 24455276)

1.

Prediction of sentinel node status and clinical outcome in a melanoma centre.

Teixeira V, Vieira R, Coutinho I, Cabral R, Serra D, Julião MJ, Brites MM, Albuquerque A, de Lima JP, Figueiredo A.

J Skin Cancer. 2013;2013:904701. doi: 10.1155/2013/904701. Epub 2013 Dec 25.

2.

Prediction of non-sentinel node status and outcome in sentinel node-positive melanoma patients.

Roka F, Mastan P, Binder M, Okamoto I, Mittlboeck M, Horvat R, Pehamberger H, Diem E.

Eur J Surg Oncol. 2008 Jan;34(1):82-8. Epub 2007 Mar 13.

PMID:
17360144
3.

Validation of a scoring system to predict non-sentinel lymph node metastasis in melanoma.

Cadili A, McKinnon G, Wright F, Hanna W, Macintosh E, Abhari Z, Dabbs K.

J Surg Oncol. 2010 Mar 1;101(3):191-4. doi: 10.1002/jso.21465.

PMID:
20039281
4.

Sentinel node status in melanoma patients is not predictive for overall survival upon multivariate analysis.

Roka F, Kittler H, Cauzig P, Hoeller C, Hinterhuber G, Wolff K, Pehamberger H, Diem E.

Br J Cancer. 2005 Feb 28;92(4):662-7.

5.

Should all patients with melanoma between 1 and 2 mm Breslow thickness undergo sentinel lymph node biopsy?

Mays MP, Martin RC, Burton A, Ginter B, Edwards MJ, Reintgen DS, Ross MI, Urist MM, Stromberg AJ, McMasters KM, Scoggins CR.

Cancer. 2010 Mar 15;116(6):1535-44. doi: 10.1002/cncr.24895.

6.

Prognostic factors associated with sentinel lymph node positivity and effect of sentinel status on survival: an analysis of 1049 patients with cutaneous melanoma.

Kunte C, Geimer T, Baumert J, Konz B, Volkenandt M, Flaig M, Ruzicka T, Berking C, Schmid-Wendtner MH.

Melanoma Res. 2010 Aug;20(4):330-7. doi: 10.1097/CMR.0b013e32833ba9ff.

PMID:
20526218
7.

Analysis of sentinel lymph node positivity in patients with thin primary melanoma.

Venna SS, Thummala S, Nosrati M, Leong SP, Miller JR 3rd, Sagebiel RW, Kashani-Sabet M.

J Am Acad Dermatol. 2013 Apr;68(4):560-7. doi: 10.1016/j.jaad.2012.08.045. Epub 2012 Nov 19.

PMID:
23182069
8.

Sentinel lymph node status as most important prognostic factor in patients with high-risk cutaneous melanomas (tumour thickness >4.00 mm): outcome analysis from a single institution.

Hinz T, Ahmadzadehfar H, Wierzbicki A, Hoeller T, Wenzel J, Biersack HJ, Bieber T, Schmid-Wendtner MH.

Eur J Nucl Med Mol Imaging. 2012 Aug;39(8):1316-25. doi: 10.1007/s00259-012-2139-3. Epub 2012 May 23.

PMID:
22618833
9.

Tumor-infiltrating lymphocytes predict sentinel lymph node positivity in patients with cutaneous melanoma.

Taylor RC, Patel A, Panageas KS, Busam KJ, Brady MS.

J Clin Oncol. 2007 Mar 1;25(7):869-75.

10.

Sentinel lymph node biopsy for melanoma: indications and rationale.

Phan GQ, Messina JL, Sondak VK, Zager JS.

Cancer Control. 2009 Jul;16(3):234-9. Review.

11.

Sentinel lymph node biopsy for cutaneous melanoma: the Stanford experience, 1997-2004.

Berk DR, Johnson DL, Uzieblo A, Kiernan M, Swetter SM.

Arch Dermatol. 2005 Aug;141(8):1016-22.

PMID:
16103331
12.

Prognostic value of sentinel lymph node biopsy in 121 low-risk melanomas (tumour thickness <1.00 mm) on the basis of a long-term follow-up.

Hinz T, Ahmadzadehfar H, Wierzbicki A, Höller T, Wenzel J, Biersack HJ, Bieber T, Schmid-Wendtner MH.

Eur J Nucl Med Mol Imaging. 2012 Apr;39(4):581-8. doi: 10.1007/s00259-011-2009-4. Epub 2011 Dec 8.

PMID:
22160198
13.

Sentinel lymph node dissection in stage I/II melanoma patients: surgical management and clinical follow-up study.

Macripò G, Quaglino P, Caliendo V, Ronco AM, Soltani S, Giacone E, Pau S, Fierro MT, Bernengo MG.

Melanoma Res. 2004 Apr;14(2):S9-12.

PMID:
15057050
14.

Single-institution experience in the management of patients with clinical stage I and II cutaneous melanoma: results of sentinel lymph node biopsy in 240 cases.

Rex J, Paradelo C, Mangas C, Hilari JM, Fernández-Figueras MT, Fraile M, Alastrué A, Ferrándiz C.

Dermatol Surg. 2005 Nov;31(11 Pt 1):1385-93.

PMID:
16416605
15.
16.

The impact of factors beyond Breslow depth on predicting sentinel lymph node positivity in melanoma.

Paek SC, Griffith KA, Johnson TM, Sondak VK, Wong SL, Chang AE, Cimmino VM, Lowe L, Bradford CR, Rees RS, Sabel MS.

Cancer. 2007 Jan 1;109(1):100-8.

17.

Sentinel lymph node biopsy for 102 patients with primary cutaneous melanoma at a single Japanese institute.

Otsuka M, Yamasaki O, Kaji T, Iwatsuki K, Asagoe K.

J Dermatol. 2015 Jun 13. doi: 10.1111/1346-8138.12972. [Epub ahead of print]

PMID:
26074328
19.

Accuracy of lymphatic mapping and sentinel lymph node biopsy after previous wide local excision in patients with primary melanoma.

Gannon CJ, Rousseau DL Jr, Ross MI, Johnson MM, Lee JE, Mansfield PF, Cormier JN, Prieto VG, Gershenwald JE.

Cancer. 2006 Dec 1;107(11):2647-52.

20.

Predictors of sentinel lymph node metastasis in melanoma.

Cadili A, Dabbs K.

Can J Surg. 2010 Feb;53(1):32-6.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk